Cao, W., Liu, X., Zhang, Y., Li, A., Xie, Y., Zhou, S., . . . Tang, X. (2021). BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib by Inhibiting PI3K/AKT/mTOR and Inducing Autophagy. Biomed Res Int.
Chicago Stili AlıntıCao, Weiya, et al. "BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib By Inhibiting PI3K/AKT/mTOR and Inducing Autophagy." Biomed Res Int 2021.
MLA AlıntıCao, Weiya, et al. "BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib By Inhibiting PI3K/AKT/mTOR and Inducing Autophagy." Biomed Res Int 2021.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..